↓ Skip to main content

PLOS

Rapid Molecular Testing for TB to Guide Respiratory Isolation in the U.S.: A Cost-Benefit Analysis

Overview of attention for article published in PLOS ONE, November 2013
Altmetric Badge

Mentioned by

policy
2 policy sources
twitter
1 X user

Readers on

mendeley
88 Mendeley
Title
Rapid Molecular Testing for TB to Guide Respiratory Isolation in the U.S.: A Cost-Benefit Analysis
Published in
PLOS ONE, November 2013
DOI 10.1371/journal.pone.0079669
Pubmed ID
Authors

Alexander J. Millman, David W. Dowdy, Cecily R. Miller, Robert Brownell, John Z. Metcalfe, Adithya Cattamanchi, J. Lucian Davis

Abstract

Respiratory isolation of inpatients during evaluation for TB is a slow and costly process in low-burden settings. Xpert MTB/RIF (Xpert) is a novel molecular test for tuberculosis (TB) that is faster and more sensitive but substantially more expensive than smear microscopy. No previous studies have examined the costs of molecular testing as a replacement for smear microscopy in this setting.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 88 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Brazil 1 1%
Unknown 86 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 14 16%
Researcher 14 16%
Student > Master 14 16%
Other 8 9%
Student > Postgraduate 6 7%
Other 14 16%
Unknown 18 20%
Readers by discipline Count As %
Medicine and Dentistry 34 39%
Agricultural and Biological Sciences 9 10%
Biochemistry, Genetics and Molecular Biology 4 5%
Immunology and Microbiology 4 5%
Social Sciences 4 5%
Other 11 13%
Unknown 22 25%